Late Feasibility Study to Evaluate Safety and Efficacy of AWAK PD Device in Subjects With ESKD.

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

March 10, 2024

Study Completion Date

July 29, 2024

Conditions
Chronic Kidney Diseases
Interventions
DEVICE

AWAK PD

Daily 7- or 9-hour therapy (with or without a last fill) that is a form of automated peritoneal dialysis being done by subjects who are already on daily PD therapy

Trial Locations (1)

Unknown

Singapore General Hospital, Singapore

Sponsors
All Listed Sponsors
collaborator

Singapore General Hospital

OTHER

lead

AWAK Technologies Pte Ltd

INDUSTRY